Standardised lung function testing
Quality control is an essential ingredient of all clinical laboratory work and it has been difficult to achieve in clinical respiratory physiology. Tests of respiratory function call for the active cooperation of an untrained individual who has to perform quite complex manoeuvres on request. To reach the position where different laboratories would produce the same result on the same patient, a number of conditions have to be met. First, the respiratory manoeuvres requested must be identical. Secondly, the apparatus must respond in the same way to the same stimulus. Thirdly, the results have to be calculated in a standard way and expressed in conventional units. Finally, the reference or normal values have to be agreed between the laboratories, if estimates of the likelihood of normality are to be provided.
The European Coal and Steel Community (ECSC) has for a long time sponsored work into pulmonary function as part of long term studies of occupational lung disease and chronic bronchitis. As a result, a working party was set up which was concerned with the standardisation of pulmonary function tests. Recommendations on the practice of spirometry were published in 1971.' Since then further tests have gained wide acceptance in epidemiology and the SI system of units has been introduced. It became apparent that there was a need for harmonisation of techniques and of nomenclature if comparable studies were to be made in different centres. The working party recognised that harmonisation was not an end in itself and that it would probably be effective only for well established routine tests. They therefore set out to review current techniques, concerning themselves mainly with those tests which are applied frequently, departing as little as possible from accepted practice in Europe and the United States. July 1981 was the date set for the publication of the first draft. This was circulated widely and suggestions from a number of experts were incorporated into the final version. The result is a lengthy report entitled "Standardized Lung Function Testing," which has been published as a supplement of the European Bulletin (Clinical Respiratory Physiology) .2 The authors, who are all notable experts in this field, have tackled all of the problems of standardisation and produced a series of recommendations which are required reading for everyone who is concerned with the organisation of a clinical respiratory laboratory. The recommendations are concerned firstly with the performance of the tests and secondly with the provision of reference values.
As the lack of accepted standards has been a major problem for epidemiologists concerned with lung disease, the National Heart and Lung Institute (NHLI) in the United States also embarked on an epidemiology standardisation project, eventually published in full in 1978.3 This document was concerned with the preparation of standard questionnaires and the reporting of chest radiographs as well as with pulmonary function, but a succinct chapter was included which dealt with spirometry, diffusing capacity and lung volumes. This study is interesting to read because the authors have taken great pains to discuss the reasons why they have chosen one course rather than another and because new work was undertaken to solve some of the problems that emerged during the preparation of the document. Fortunately, the ECSC working party have generally made the same recommendations, though they have taken rather less trouble to explain their conclusions. The task of reading the sections which deal with individual tests is somewhat daunting. To make their recommendations comprehensible, the authors have provided considerable detail about how they think the standard tests should be carried out. Even so, the work is not a complete manual of lung function testing, and the summary provided unfortunately does not tally in every detail with the contents of the principal chapters. The purpose of this review is to examine the consequences of following the recommendations in the ECSC document.
Static lung volumes VITAL CAPACITY
Vital capacity is defined as the volume change at the mouth between the positions of full inspiration and full expiration. The Working Party have proposed that expired vital capacity (EVC) and inspired vital 881 882 capacity (IVC) should be measured separately and specified for certain situations.
Inspired vital capacity is greater than expired vital capacity in patients with chronic airflow obstruction and it is therefore recommended (1) for the calculation of FEV1/VC, the Tiffeneau index, and (2) for the calculation of residual volume and total lung capacity: RV = TLC -IVC It is true that because of the difference between forced vital capacity EVC and IVC in patients with chronic airflow obstruction, the ratio FEV1/VC is a better discriminator than FEVI/FVC and is correlated with the severity of emphysema in patients with chronic airflow obstruction.4 EVC can be measured on portable equipment, while IVC requires a more elaborate spirometer. In normal subjects and patients without airflow obstruction, FVC is usually greater than EVC and identical to Ivc.
LUNG VOLUMES: CHOICE OF METHOD
The section on lung volumes reflects the change in opinion during the preparation of successive drafts which has arisen as a result of the demonstration of serious problems with the use of body plethysmography in patients with airflow obstruction.56 Body plethysmography is recommended as the method of choice in patients with chronic airflow obstruction but with a warning of the possible overestimate which may occur in the presence of airway closure when this method is employed.
Radiographic methods give similar results to body plethysmography and closed circuit inert gas dilution methods in subjects with normal intrapulmonary gas mixing.'8 In a series of 19 healthy controls, a small positive difference was accounted for entirely by those who had smoked cigarettes. 9 The average difference between residual volume measured by closed circuit helium dilution and by the single breath method with 10 seconds of breath holding is -0 1 I +/-0-7 (2 SD) in patients with lung diseases not characterised by airflow obstruction in whom FEV,/VC is normal (Laszlo, unpublished observations). In 80% of patients with chronic bronchitis and emphysema, however, the difference is greater than 0-7 1.10 There is a corresponding difference between TLC measured radiographically and by closed circuit helium dilution using an equilibration time of up to 10 minutes. The magnitude of the latter difference is dependent on the severity of the airflow obstruction and on the topographical distribution of emphysema, peripheral lesions apparently filling with helium more slowly than central emphysema.4 9 The Working Party concluded that more research was needed into use of forced breathing during closed circuit helium dilution in the estimation of lung volumes and into possible modifications to plethysmographic methods to achieve accurate results in patients with chronic airflow obstruction. It seems likely that a technique which involves panting near TLC at controlled low frequencies will be shown to produce a good estimate of thoracic gas volume even in the presence of quite severe airflow obstruction.5 "1 Meanwhile, the best starting point at present for calculating the subdivisions of lung volume in these patients is probably the radiographic measurement of TLC,8 12 provided that there is no thoracic deformity.
TECHNIQUE
For body plethysmography the mean of three estimations of FRC is recommended. Then: TLC = FRC + inspiratory capacity (IC) (largest of 3) and RV = TLC -IVC. For closed circuit helium dilution, only one measurement is recommended. Unfortunately, there are a number of sources of potential error in this section. Firstly a rebreathing time of up to 10 minutes is suggested, which may be cut short if the helium reading is stable for two minutes. This conforms with common practice. Elsewhere, it is stated that 20 minutes is required for full equilibration when there is severe chronic airflow obstruction, but experience suggests that this is rarely satisfactory because leakage is common with long rebreathing times and there is a theoretical possibility that helium may be swallowed.
Secondly it is suggested that attempts to stabilise the trace should be abandoned after one minute and the effect of drift corrected by a formula. This is acceptable in subjects with rapid intrapulmonary mixing, if the katharometer reading can be corrected for the error To define the start of forced expiration after full inspiration, backward extrapolation of the fastest portion of the curve is preferred to the practice of discarding the convex first portion of the curve, usually 0-1 litres. The latter convention, however, has been convenient in ordinary clinical spirometry as the kymographs of bellows spirometers are conveniently activated at the start of expiration by the movement of the volume recording arm. The difference between the two methods is unimportant. The envelope method of analysis is recommended, whereby the curves are superimposed graphically at TLC and the highest value of each index is taken. The alternative method given is easier to use if the method is to be computerised. MEF at 75%, 50% and 25% FVC are taken to be the highest value obtained from each of the three largest FVC tests, FVC varying by not more than 5%. For results before and after helium, FVC should not differ by more than 02 litres.
The poor reproducibility of flow-volume indices and their limited value in the absence of good reference data are recognised. It is assumed that the measurements will be made during dynamic spirometry. For physiological studies such as the construction of isovolume pressure-flow curves it is necessary to measure changes of thoracic volume in a body plethysmograph, when different curves are obtained in the presence of very minor degress of airflow obstruction.
CHANGE
The document contains no discussion about how bronchodilator studies or challenge tests should be performed. It is suggested that change between two measurements x, and x2 should be reported as a fraction of the mean of the two measurements (and not of the initial value):
X2-xlI05 (X2 + X,)
Because of the problem of regression to the mean'4 this is theoretically the correct way of expressing the difference between two serial results. It would be impossible to analyse dose-response curves, challenge studies and diurnal variation in this way and no evidence is presented to show that this suggestion has any practical value.
Because changes or improvements in FVC are generally caused by changes in RV, rather than TLC, it is suggested that MEFV curves after being superimposed at TLC should be recorded as the change in MEFV at 50% of initial FVC. This recommendation seems sensible (though it would have been more consistent to have chosen MEF at 50% of mean FVC.)
The NHLI document discussed this in detail and, while the ECSC working party had access to more data, they reached the same conclusion. FEV, and FVC should each be recorded as the best of three technically satisfactory attempts'5 not exceeding the next best by more than 0 3 litres. Two practice attempts are allowed but after eight attempts the procedure should always be abandoned. Falling values should be noted as indicating the onset of bronchoconstriction or fatigue.
This approach assumes that all the errors are in the direction of under-reading. While this may be true for instruments of high inertia such as the Vitalograph, readings on critically balanced instruments such as the Garw bellows spirometer tested by Ullah et al'6 are normally distributed, which suggests that, after the learning effect has been eliminated, over-reading should be as common as under-reading. These considerations lead to the choice of the mean of the best three of five readings.
The working party considered this and thought the improvement in reproducibility not to be cost effective.
What constitutes a technically satisfactory test is not defined. In practice, it means that the subject appears to have taken a full inspiration, held it until the start of a maximal forced expiration and then to have exhaled fully and forcefully without leaks or closure of the glottis. It follows that the operator must see the trace as soon as it has been generated.
Instruments that generate numbers alone do not meet this strict criterion, although experienced operators and patients regularly obtain good results from such devices as peak flow meters in wards and in domiciliary studies as well as in the laboratory.
Other tests
The chapter on transfer factor (diffusing capacity) contains little new material and in general follows the advice of Cotes.'7 Correction for haemoglobin according to a formula is recommended. Kco is defined as Th (STPD)/VA (BTPS).
The sections dealing with lung elasticity and airways resistance spell out useful criteria for the characteristics of the instruments employed but offer little advice about how best to present the results. Presumably it was recognised that these techniques are not routine and that each application requires a slightly different approach.
Reference values
The entire literature on reference values has been reviewed critically, an immense undertaking. Summary equations, based on the most acceptable data, were obtained by calculating sample results for hypothetical individuals of each combination of height and age, without weighting for the number of subjects in each study.
The working party deplored the recent trend whereby smokers are excluded from normal populations, because it has led to the publication of reference values which are regarded as unrealistically large for populations which include a high proportion of smokers and therefore reduced the usefulness of reference values as indicators of disease. The possibility of producing useful separate reference values for different groups of smokers and for non-smokers is not discussed explicitly. It is evident from the detailed tables given that this would not at present be feasible, though it would be desirable. In environmental research, the differences from normality being sought are generally too small to permit the use of published normal data and controls are necessary for each study. In To make use of published information in clinical practice it is necessary to know how it was obtained. Editors should ask for accurate descriptions of methods used, including formulae. It is equally important for authors to insist that their methods sections are not cut excessively when their work appears in general journals or in journals which purport to cater for clinicians.
The ECSC recommendations are in general sensible and deserve wide discussion by those responsible for the provision of lung function services. The alternative approaches are listed rather than discussed; this will make debate a little more difficult than it should be. Nonetheless, the summary provides useful guidelines which, if widely accepted, should be particularly valuable for reference when buying equipment and setting up new projects. 
